MedPath

Comparative evaluation of medical RF beauty devices and home-use facial device in continuous use

Not Applicable
Conditions
Healthy adult Female
Registration Number
JPRN-UMIN000053609
Lead Sponsor
Japan Clinical Trial Association
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects with serious underlying diseases (diabetes, dyslipidemia, cardiovascular disease, osteoporosis, autoimmune disease, etc.) 2. Subjects with chronic skin diseases such as atopic dermatitis 3. Subjects with a history of other serious diseases 4. Currently undergoing hospitalization, medication, or treatment for any disease. 5. Subjects have sensitive skin. 6. Subjects, lactating, or possibly pregnant. 7. Subjects who have undergone immunosuppression or other procedures within the past 3 months. 8. Subjects who have gold threads implanted or are taking or have a history of taking gold preparations (Siozol, Glelease, Rizasto, Ridora, etc.) 9. Subjects who are using a pacemaker or implantable cardioverter defibrillator 10. Subjects who have scars, warts, pimples, art makeup, burns, etc. on the face that may affect the evaluation measurement. 11. Subjects who have any experience of cosmetic or other medical treatment that may affect the subject area (including hyaluronic acid injections, Botox, etc.) 12. Subjects who have more than 5 metallic objects (bolts, silver teeth, etc.) in the treatment of the upper jaw. 13. Subjects who are undergoing dental treatment (braces, implants, etc.) 14. Subjects who may have allergic reactions to test product ingredients. 15. Claustrophobia 16. Subjects who have a smoking habit. 17. Subjects who have difficulty in maintaining their lifestyle (diet, exercise, sleep, skin care, etc.) 18. Subjects who drink excessively (e.g., more than 500 ml of beer, 1 cup (180 ml) of sake, 2 glasses (200 ml) of wine)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath